The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells

Cancer Immunology Immunotherapy

Volumn 43, Issue 1, 1996, Pages 31-38

  Kurosawa, Shin ^a   Harada, Mamoru ^a   Shinomiya, Yoshihiro ^a   Terao, Hiroshi ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antitumor vaccination; IFN ; NK cells; OK432

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; PICIBANIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ADOPTIVE TRANSFER; ANIMALS; EXUDATES AND TRANSUDATES; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; KINETICS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASMS; PERITONEAL CAVITY; PHENOTYPE; PICIBANIL; SPLEEN; STIMULATION, CHEMICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029801524     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050300     Document Type: Article

References (33)

1. Abe J, Wakimoto H, Aoyagi M, Hirakawa K, Hamada H (1995) Cytokine-gene-modified tumor vaccination intensified by a streptococcal preparation OK-432. Cancer Immunol Immunother 41:82
2. Allison JP, Hurwitz AA, Leach DR (1995) Manipulation of costimulatory signals to enhance antitumor T-cell responses. Current Opinion Immunol 7:682
3. Bancroft GJ, Sheehan KC, Schreiber RD, Unanue ER (1989) Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol 143:127
4. Blieden TM, McAdam AJ, Frelinger JG, Lord EM (1991) Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor. J Immunol 147:1433
5. Bonavida B, Katz J, Hoshino T (1986) Mechanism of NK activation by OK432. I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells. Cell Immunol 102:126
6. Chen L, Linsley PS, Hellström KE (1993) Costimulation of T cells for tumor immunity. Immunol Today 14:483
7. Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K (1993) Autoreactive and heat shock protein 60-recognizing CD4+ T cells show antitumor activity against syngeneic fibrosarcoma. Cancer Res 53:106
8. Herberman RB (1982) NK cells and other natural effector cells. Academic Press, New York, p 145
9. Ichimura O, Suzuki S, Sugawara Y, Osawa T (1984) Characterization of mouse natural killer cell activating factor (NKAF) induced by OK432:evidence for interferon- and interleukin 2-independent NK cell activation. Br J Cancer 50:97
10. Karre K, Klein GO, Kiessling R, Klein G, Roder JC (1980) In vivo NK-activity and in vivo resistance to leukemia: studies of beige, beige/nide and wild-type hosts on C57BL background. Int J Cancer 26:789
11. Kasahara T, Djeu JY, Dougherty SF, Oppenheim JJ (1983) Capacity of human large granular lymphocyte (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol 131:2379
12. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827
13. Kurosawa S, Matsuzaki G, Harada M, Ando T, Nomoto K (1993) Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development. Eur J Immunol 23:1029
14. Kurosawa S, Harada M, Matsuzaki G, Shinomiya Y, Terao H, Kobayashi N, Nomoto K (1995) Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of antitumour T lymphocytes. Immunology 85:338
15. Lee YC, Luh SP, Wu RM, Lee CJ (1994) Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection. Cancer Immunol Immunother 39:269
16. Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN (1992) Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer: a randomized trial. Cancer 69:674
17. Mayordomo JI, Zorina T, Storkus, WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat Med 1:1297
18. Okamoto M, Kaji R, Kasetani H, Yosshida H, Moriya Y, Saito M, Sato M (1993) Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432. J Immunother 13:232
19. Ortaldo JR, Herberman RB (1984) Heterogeneity of natural killer cells. Annu Rev Immunol 10:359
20. Saito M, Nanjo M, Aonuma E, Noda T, Nakadate I, Ebina T, Ishida N (1984) Activated macrophages arc responsible tor the tumor-inhibitory effect in mice receiving intravenous injection of OK-432. Int J Cancer 33:271
21. Shinomiya Y, Harada M, Kurosawa S, Okamoto T, Terao H, Matsuzaki G, Shirakusa T, Nomoto K (1995) Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing ThI type CD4+ T cells. Immunobiology 193:439
22. Shirai M, Watanabe S, Nishioka M (1990) Intratumoral injection of OK432 and lymphokine-activated killer activity in peripheral blood of patients with hepatocellular carcinoma. Eur J Cancer 26:965
23. Shitara K, Ichimura O, Mitsuno T, Osawa T (1985) Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an antitumor streptococcal preparation, OK432. J Immunol 134:1039
24. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR (1980) Role of NK cells in tumour growth and metastasis in beige mice. Nature 284:622
25. Trinehieri G (1993) Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 14:335
26. Uchida A, Micksche M (1982) Augmentation of NK cell activity in cancer patients by OK432. Activation of NK cells and reduction of suppressor cells. In: Herberman RB (ed) NK cells and other natural effector cells. Academic Press, New York, p 1303
27. Uchida A, Micksche M (1983) Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK-432. J Natl Cancer Inst 71:673
28. Uchida A, Micksche M, Hoshino T (1984) Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes. Cancer Immunol Immunother 18:5
29. Van den Eynde B, Brichard VG (1995) New tumor antigens recognized by T cells. Current Opinion Immunol 7:674
30. Watanabe Y, Iwa T (1984) Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432. Cancer 53:248
31. Watabe S, Sendo F, Kimura S, Arai S (1984) Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432. J Natl Cancer Inst 72:1365
32. Yamaue H, Katsumi M, Tabuse K, Tabuse Y, Kuribayashi K, Nishihara T, Saito K (1987) Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK 432. Cancer Immunol Immunother 25:169
33. Young HA, Ortaldo JR (1987) One-signal requirement for interferon-γ production by human large granular lymphocytes. J Immunol 139:724